Dr. Glick is an infectious disease epidemiologist whose research focuses on understanding substance use patterns, co-morbidities, and disease prevention strategies among people who use drugs. She works as an epidemiologist in the HIV/STD Program at Public Health – Seattle & King County (PHSKC) where she oversees CDC-funded and local surveillance projects.
She is the principal investigator for a CDC-led project to establish and support a national monitoring and evaluation system for syringe services programs (SSP). Over the past three years, the Strengthening Harm Reduction Programs (SHaRP) team has: conducted a multi-site survey of >1,500 people who use drugs at six U.S. SSPs, conducted a national survey of SSPs, and provided technical assistance related to monitoring and evaluation at SSPs through CDC’s Harm Reduction Technical Assistance Center. The team has also conducted qualitative research to understand the impact of COVID-19 on SSP operations.
Dr. Glick is also the site PI for the Seattle-area National HIV Behavioral Surveillance (NHBS) system, which includes surveys of populations at risk for HIV including men who have sex with men, people who inject drugs, heterosexually-active people, women who exchange sex for money or drugs, and transgender women. Data from these surveys has been used to describe the increasing use of methamphetamine, the HCV care continuum, and the use of medications for opioid use disorder among people who inject drugs in Seattle.
- substance use
- hepatitis C virus
- harm reduction
- public health surveillance
Education & Training:
BA, Anthropology, Northwestern University (2002)
MPH, Epidemiology, University of Illinois - Chicago (2004)
PhD, Epidemiology, University of Washington (2010)